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Abstract Pneumocystis pneumonia remains the most common
AIDS-de¢ning opportunistic infection in people with HIV. The
process by which Pneumocystis carinii constructs its cell wall is
not well known, although recent studies reveal that molecules
such as L-1-3-glucan synthetase (GSC1) and environmental pH-
responsive genes such as PHR1 are important for cell-wall in-
tegrity. In closely related fungi, a speci¢c mitogen-activated
protein kinase (MAPK) cascade regulates cell-wall assembly
in response to elevated temperature. The upstream mitogen-ac-
tivated protein kinase kinase kinase (MAPKKK, or MEKK),
BCK1, is an essential component in this pathway for maintain-
ing cell-wall integrity and preventing fungal cell lysis. We have
identi¢ed a P. carinii MEKK gene and have expressed it in
Saccharomyces cerevisiae to gain insights into its function.
The P. carinii MEKK, PCBCK1, corrects the temperature-sen-
sitive cell lysis defect of bck1v yeast. Further, at elevated tem-
perature PCBCK1 restored the signaling defect in bck1v yeast
to maintain expression of the temperature-inducible L-1-3-glu-
can synthetase gene, FKS2. PCBCK1, as a functional kinase, is
capable of autophosphorylation and substrate phosphorylation.
Since glucan machinery is not present in mammals, a better
understanding of this pathway in P. carinii might aid in the
development of novel medications which interfere with the in-
tegrity of the Pneumocystis cell wall.
/ 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Pneumocystis pneumonia remains the most common AIDS-
de¢ning opportunistic infection in people infected with the
human immunode¢ciency virus (HIV) [1^4]. Once inhaled
from the environment into the lungs of an immunosuppressed
host, Pneumocystis carinii binds to the alveolar epithelium and
causes damage through an elaborate induction of host in£am-
matory responses [5^9]. Although the natural reservoir for
P. carinii is not known, its nucleic acids have been isolated
in the air in hospitals and unexpected environments such as
apple orchards and ponds [10^16]. It is unknown whether
P. carinii has the ability to adapt to di¡erent environmental
stresses such as temperature, however a phylogenetically re-
lated ascomycete, Saccharomyces cerevisiae, activates a specif-
ic mitogen-activated protein kinase (MAPK) cascade upon a
temperature increase from 25‡C to 37‡C (similar to the tran-
sition from room temperature to body temperature). The
S. cerevisiae mitogen-activated protein kinase kinase kinase
(MAPKKK, or MEKK) BCK1 is critical for maintaining
cell-wall integrity at elevated temperature [17^22]. Disruption
of the cell-wall integrity MAPK pathway results in fungal
death at the elevated temperature due to loss of inducible
L-1-3-glucan synthetase function within 2 h, however addition
of an osmotic stabilizing agent, such as sorbitol, will amelio-
rate this e¡ect and allow the fungi to grow at the elevated
temperature [18,20,22].
The principal component of the fungal cell wall is glucan,
which is comprised of homopolymers of glucose molecules
with a L-1,3-linked carbohydrate core and side chains of
L-1,6- and L-1,4-linked glucose [23^27]. Indeed, the glucan
present in the P. carinii cell wall is responsible for the signi¢-
cant in£ammatory response in the lungs of the infected host
[6]. In S. cerevisiae, FKS1 and FKS2 encode subunits of the
L-1-3-glucan synthetase, which mediate the polymerization of
uridine 5P-diphosphoglucose into L-1,3-glucan. We have pre-
viously isolated a P. carinii L-1-3-glucan synthetase gene,
GSC1, which has homology to both FKS1 and FKS2 [23].
FKS1 is predominantly expressed under optimal growth con-
ditions at temperatures ranging from 25‡C to 30‡C [28^30].
FKS2 is induced within 20 min in response to elevated temper-
ature (37‡C or greater) to increase the stability of the yeast
cell wall. Dual pathways participate in the induction of FKS2
expression, a calcineurin-mediated pathway and the cell-wall
integrity MAPK pathway, however maintenance of FKS2 ex-
pression after 60 min of continued heat stress requires a func-
tioning cell-wall integrity MAPK pathway [22,31]. Perturba-
tion of fungal cell-wall assembly represents an attractive target
for the treatment of fungal infections, since the biosynthetic
machinery for generating glucan is not present in mammals
[32^34].
Our laboratory has demonstrated that P. carinii molecules
such as the L-1-3-glucan synthetase GSC-1 and environmental
pH-responsive genes such as PHR1 participate in cell-wall
maintenance [23,24]. Unfortunately, the inability to culture
P. carinii outside of the infected host and the inability to
overexpress or disrupt genes in P. carinii make direct analysis
of these pathways impossible. Hence, we report the identi¢ca-
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tion of a P. carinii gene encoding a MEKK, PCBCK1, and we
investigate PCBCK1 e¡ects on cell-wall integrity signaling in
S. cerevisiae bck1v mutants.
2. Materials and methods
2.1. Materials
All chemical reagents were purchased from Sigma Chemical (St.
Louis, MO, USA). Restriction endonucleases, Taq DNA polymerase
and Platinum Pfx DNA polymerase were purchased from Invitrogen.
PHAS-I substrate was purchased from Stratagene. [Q32P]ATP was
obtained from ICN Pharmaceuticals.
2.2. Preparation of P. carinii organisms
All studies described in this report were approved by the institu-
tional animal care and use committee. P. carinii pneumonia was in-
duced in Harlan Sprague^Dawley rats by immunosuppression with
dexamethasone as previously reported [23,24,35^38]. Lungs from mor-
ibund rats were minced and homogenized in HBSS and P. carinii were
puri¢ed from host lung cells by ¢ltration through a 10-Wm ¢lter (Milli-
pore). P. carinii organisms were con¢rmed by Wright^Giemsa staining
and samples containing contaminating bacterial or fungal organisms
were discarded.
2.3. Cloning and chromosomal location of the PCBCK1 gene
A degenerate polymerase chain reaction (PCR)-based approach was
used to obtain a partial clone of the P. carinii BCK1, followed by
library screening to obtain the full-length cDNA sequence. Degener-
ate PCR was performed in a 50-Wl reaction that included 1U PCR
bu¡er, 50 WM dNTPs, 2 WM each of the primers ELMAVKQV
(5P-GARYTNATGGCWGTWAARCARGT-3P) and NAGKIDRH
(5P-TTWGCWCCYTTWATRTCNCGRTG-3P), 250 ng of P. carinii
genomic DNA, and 1.25 units of Taq DNA polymerase. Samples were
ampli¢ed for 30 cycles at 94‡C for 60 s, 56‡C for 60 s, and 72‡C for
60 s, and the PCR products were subjected to electrophoresis on 2%
agarose. A single 373-bp amplicon was visualized by ethidium bro-
mide staining and was ligated into a pGEM T-Easy plasmid (Prom-
ega), and completely sequenced. The PCR amplicon was used as a
probe to screen a rat-derived P. carinii cDNA library in the Uni-ZAP
XR bacteriophage as previously described (NIH AIDS Research Re-
agent Program, Bethesda, MD, USA) [35,36]. The phagemid was
excised using the M13 helper phage and the P. carinii BCK1 insert
was sequenced. The entire P. carinii BCK1 cDNA was ampli¢ed by
PCR using the proofreading Platinum Pfx DNA polymerase and the
following primers: 5P-ATGGATTATTTAAAGAAAGT-3P (sense)
and 5P-TTTTTTTGCATCAGTCAAAG-3P (antisense). Following
ampli¢cation, 1 unit of Taq DNA polymerase was added at 72‡C
for 30 min and the gene was ligated into the yeast expression plasmid
pYES2.1 TOPO TA (Invitrogen), then sequenced entirely to con¢rm
the absence of PCR errors and to con¢rm correct orientation.
PYES2.1 TOPO TA has the galactose-regulated promoter GAL1,
which induces transcription when the yeast are grown in galactose
as a carbon source, and a carboxyl V5 epitope tag (Gly-Lys-Pro-Ile-
Pro-Asn-Pro-Leu-Leu-Gly-Leu-Asp-Ser-Thr), allowing identi¢cation
of fusion proteins with an anti-V5 antibody (Invitrogen). The stop
codon for PCBCK1 was not included to allow in-frame fusion to
the C-terminal V5 epitope tag. The chromosomal location of
PCBCK1 was determined by ¢rst labeling the PCBCK1 373-bp
PCR amplicon with [32P]K-dATP by the random primer method, fol-
lowed by hybridization to P. carinii chromosomes separated by con-
tour-clamped homogenous ¢eld electrophoreses (CHEF).
2.4. Site-directed mutagenesis
The lysine in PCBCK1 at position 575 corresponds to the conserved
lysine which is essential for catalytic activity in the kinase domain of
protein kinases. We used site-directed mutagenesis to change the ly-
sine to an arginine, which has been previously shown to abolish kinase
activity but not lead to instability of the protein [39^41]. To create
PCBCK1vK575R, we generated a sense mutagenesis primer 5P-GGA-
GAATTGATGGCAGTACGACAAGTTGAAATACCGTCT-3P and
an antisense mutagenesis primer 5P-AGACGGTATTTCAACTTGT-
CGTACTGCCATCAATTCTCC-3P to create the desired mutation.
These oligonucleotides were annealed to PCBCK1 in the pYES2.1
plasmid and the mutations were generated by PCR following the
instructions by the manufacturer (Stratagene QuikChange Multi
Site-Directed Mutagenesis). Following mutagenesis the plasmid was
sequenced to verify the correct mutation was generated.
2.5. Yeast strains, plasmids, and transformation
S. cerevisiae used in this study was obtained from ATCC: bck1v
(MATa his3-1, leu2-0, ura3-0, met15-0, bck1: :kanR). For the purposes
of positive controls, the S. cerevisiae BCK1 gene was ampli¢ed by
PCR with the proofreading Platinum Pfx DNA polymerase using
the following primers: 5P-ATGCCCTTTTTGAGGAAAATAGCG-
GGGAC-3P (sense) and 5P-TTCAGTTTTATTCTCCTGAGAGGT-
TATCCTT-3P (antisense) and ligated into the yeast expression plas-
mid pYES2.1 TOPO TA (Invitrogen), then sequenced to con¢rm the
absence of PCR errors. The stop codon for SCBCK1 was not included
to allow in-frame fusion to the C-terminal V5 epitope tag. Yeast
were grown overnight in YEPD media containing 200 mg l31 G418
at 30‡C to an OD600 of 1.0, then transformed with the plasmids
pYES2.1/PCBCK1, pYES2.1/SCBCK1, pYES2.1/PCBCK1vK575R, or
pYES2.1/LACZ by electroporation as previously described [24,36,
37]. Transformants were selected on glucose minimal media lacking
uracil at 30‡C.
2.6. Northern analysis
Expression of PCBCK1 was determined by northern analysis.
P. carinii total RNA was isolated with Trizol Reagent (Invitrogen),
and 10 Wg were separated on 1.0% formaldehyde-agarose gels, trans-
ferred to Nytran Plus membranes (Schleicher and Schuell; Keene,
NH), and probed with radiolabeled PCBCK1. Following exposure
to autoradiography ¢lm, the membranes were re-probed using a ra-
diolabeled P. carinii actin probe. Temperature induction of FKS2
mRNA expression was performed following the procedure described
by Zhao et al. [22]. S. cerevisiae bck1v yeast and bck1v yeast trans-
formed with pYES2.1/PCBCK1 were grown to mid-log phase
(OD600 = 0.8) at 25‡C in YEPD containing 200 mg l31 G418 or ga-
lactose minimal media, respectively. An immediate temperature shift
to 37‡C was achieved by adding an equal volume of media pre-
warmed at 55‡C to the cultures and placing them in a 37‡C shaking
water bath. Cultures were removed at various time points, pelleted,
and total RNA was isolated with YeastarRNA (Zymo Research) fol-
lowing the instructions of the manufacturer. Five micrograms of total
RNA was separated on 1.0% formaldehyde-agarose gels and trans-
ferred to Nytran Plus membranes. S. cerevisiae FKS1 and FKS2
probes were generated by PCR using the primers, respectively:
5P-ATGAACACTGATCAAC-3P (sense) and 5P-AATTACCGTAA-
ATTGG-3P (antisense) and 5P-ATGTCCTACAACGATCC-3P (sense)
and 5P-GAACCATCTTGATCAGG-3P (antisense) [22]. SCFKS1,
SCFKS2 and ACTIN probes were labeled by the random primer
method using [32P]K-dATP, hybridized at 68‡C using Clontech Ex-
press Hybridization Solution (Clontech, Inc.; Palo Alto, CA, USA),
and exposed to autoradiography ¢lm.
2.7. Temperature-induced cell lysis assays
S. cerevisiae bck1v yeast transformed with pYES2.1/PCBCK1,
pYES2.1/SCBCK1, pYES2.1/PCBCK1vK575R, or pYES2.1/LACZ
were grown on minimal media plates at 30‡C and 37‡C containing
galactose or galactose supplemented with 1 M sorbitol (used as an
osmotic stabilizing agent). The plates were photographed after 7 days.
2.8. Immunoblotting
Protein lysates were extracted from S. cerevisiae using the YPER
reagent (Pierce) containing a protease/phosphatase inhibitor cocktail
(1 Wg ml31 each of leupeptin, aprotinin, and pepstatin; 1 mM each of
phenylmethylsulfonyl £uoride and sodium orthovanadate; and 50 mM
sodium £uoride). Soluble proteins were boiled in Laemmli bu¡er,
separated by sodium dodecyl sulfate (SDS)^polyacrylamide gel elec-
trophoresis, and transferred to nitrocellulose membranes. Non-speci¢c
binding sites were blocked with TBS containing 5% milk prior to
incubation with the anti-V5 antibody for 1 h. Immunoreactive bands
were visualized by enhanced chemiluminescence (Amersham Pharma-
cia Biotech) following the procedures recommended by the manufac-
turer.
2.9. Autophosphorylation and substrate kinase assays
S. cerevisiae bck1v yeast transformed with pYES2.1/PCBCK1 or
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pYES2.1/PCBCK1vK575R were grown to mid-log phase (OD600 = 0.8)
at 25‡C in galactose minimal media and rapidly shifted to 37‡C as
described above. The yeast were lysed in YPER reagent (Pierce) con-
taining 1 Wg ml31 each of leupeptin, aprotinin, and pepstatin; 1 mM
each of phenylmethylsulfonyl £uoride and sodium orthovanadate;
and 50 mM sodium £uoride for 20 min at room temperature. The
suspension was clari¢ed by centrifugation at 13 000Ug for 10 min and
the protein concentration of the lysates was determined spectrophoto-
metrically using the BCA method (Pierce). Protein lysate (500 Wg) was
precleared with a 50% slurry of protein A^Sepharose at 4‡C for
30 min, and the protein was immunoprecipitated at 4‡C for 2 h using
the anti-V5 antibody (dilution 1:5000). The immunocomplexes were
captured with protein A^Sepharose and were washed twice in lysis
bu¡er (50 mM Tris^HCl, pH 7.5, 100 mM NaCl, 50 mM NaF, 1%
Triton X-100, 1 mM EDTA, 1 mM sodium orthovanadate, 1 mM
phenylmethylsulfonyl £uoride, 1 Wg ml31 each of leupeptin, aprotinin,
and pepstatin) and twice in kinase bu¡er [50 mM HEPES, pH 7.5,
10 mM MgCl2, 10 mM MnCl2, 1 mM dithiothreitol (DTT)]. The
immunocomplexes were added to a 40 Wl reaction containing 50 mM
HEPES, pH 7.5, 10 mM MgCl2, 1 mM DTT, 2 Wg of PHAS-I, 20 WM
ATP, and 10 WCi [32P]Q-ATP. In vitro kinase reactions to test sub-
strate phosphorylation were incubated at 30‡C for 30 min., while
autophosphorylation was performed without the addition of PHAS-
I to the kinase reaction and incubation was at 30‡C for 2 h. Kinase
reactions were stopped with the addition of Laemmli bu¡er, boiled for
5 min, resolved by electrophoresis on 12% SDS^polyacrylamide gels,
and submitted to autoradiography.
3. Results
3.1. Cloning, chromosomal location, and mRNA expression of
PCBCK1
Molecular cloning of PCBCK1 was performed using a de-
generate PCR strategy and traditional library screening (Fig.
1A). We designed degenerate oligonucleotide primers derived
from conserved amino acid sequences of fungal MEKK pro-
teins. An initial 373-bp PCR amplicon was obtained and was
found to be unique on NCBI GenBank analysis but homolo-
gous to S. cerevisiae BCK1. To further con¢rm that the PCR
product was speci¢cally represented within the P. carinii ge-
nome, the 373-bp PCR amplicon was hybridized to P. carinii
chromosomes separated by CHEF. The probe hybridized to a
single chromosomal band (Fig. 2), demonstrating that
PCBCK1 is represented within the P. carinii genome. Using
of the 373-bp PCR amplicon as a probe, a 2472-bp full-length
cDNA was obtained by screening a P. carinii cDNA library in
the bacteriophage Uni-Zap XR (GenBank accession number
AF312696). Using this same probe, we identi¢ed two mRNA
transcripts for PCBCK1 (Fig. 3). The observed transcript sizes
are 2500 and 2600 bp, which might indicate alternative splic-
ing of the PCBCK1 gene.
Fig. 1. Nucleotide and predicted amino acid sequence of PCBCK1. NCBI GenBank accession number AF312696. The open reading frame of
PCBCK1 is 2472-bp (A), which encodes a protein of 823 amino acids with a predicted molecular weight of 92.9 kDa. Conserved amino acids
motifs are shaded gray, and include SAM from amino acids 21^79, the Ras association domain from amino acids 192^268, and the serine/
threonine protein kinase domain from amino acids 546^810 (B). Multiple sequence alignment demonstrates homology in the carboxy terminal
of these proteins (C).
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Fig. 1 (Continued).
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Fig. 1 (Continued).
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3.2. PCBCK1 contains conserved protein domains
Analysis of the translated cDNA of PCBCK1 demonstrates
a molecule of 823 amino acids and predicted molecular mass
of 92.9 kDa (Fig. 1B). PCBCK1 has 47% identity to S. cere-
visiae BCK1 using the NCBI database BLASTX (translated
nucleotide query to protein database). Additional homology
includes 39% identity to S. pombe BYR2 (M74293), and 35%
identity to S. cerevisiae STE11 (U19103). The putative protein
sequence has three highly conserved protein domains. In the
N-terminal region there is a sterile alpha motif (SAM) present
from amino acids 21^79. SAM is a protein domain found in
signaling molecules which can act as a binding site for SH2-
containing proteins such as sca¡olding proteins and facilitate
native protein homodimerization [20,42^44]. The PCBCK1
SAM domain is homologous to the fungal SAM domains
found in S. cerevisiae BCK1, STE11, BOB1, BOI2, S. pombe
Byr2, and Kluyveromyces lactis BCK1 (NCBI Conserved Do-
main Database). The amino acid sequence from 192^268 of
PCBCK1 contains a Ras association domain (RalGDS/AF-6)
which has been shown in some cases to bind RasGTP. This
domain is homologous to the RAS domains found in fungal
adenylyl cyclase proteins from S. cerevisiae, Magnaporthe gri-
sea, S. pombe, Podospora anserina, and Neurospora crassa,
and to the S. cerevisiae proteins STE4 and STE50 [45,46].
Fig. 1 (Continued).
Fig. 2. Chromosomal location of PCBCK1. P. carinii chromosomes
were separated by CHEF. PCBCK1 hybridized to a single chromo-
some. L indicates the molecular weight ladder and the PCBCK1 hy-
bridization is indicated by *.
Fig. 3. mRNA expression of PCBCK1. Two transcripts are detected
from RNA isolated from P. carinii organisms hybridized with a ra-
dioactively labeled PCBCK1 (lane A). The approximate sizes are
2500 and 2600 bp (arrows). Lane B demonstrates the same blot re-
probed with P. carinii actin.
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Toward the carboxyl terminal there is a highly conserved
serine/threonine protein kinase catalytic domain (amino acids
546^810). Protein alignment of PCBCK1 with S. cerevisiae
STE11 and BCK1, S. pombe Byr2, and human MEKK1 re-
veals signi¢cant homology occurring toward the carboxy ter-
minal of the proteins (Fig. 1C).
3.3. PCBCK1 complements cell-wall integrity signaling in
S. cerevisiae bck1v yeast
We expressed PCBCK1 in S. cerevisiae bck1v mutant yeast
in order to gain insight in the function of this gene. These
mutant yeast, with their BCK1 deleted, will lyse at the non-
permissive temperature of 37‡C due to disruption of MAPK
signaling at the level of the absent BCK1 gene. Growth can
occur at the non-permissive temperature if an osmotic stabi-
lizing agent such as sorbitol is added to the yeast [18,20].
PCBCK1 allows growth of the bck1v yeast at 37‡C, as does
the positive control, S. cerevisiae BCK1 (Fig. 4A). As ex-
pected, the LACZ gene expressed in these yeast fails to com-
plement the signaling defect and growth cannot occur at the
elevated temperature. To access whether the observed comple-
mentation was speci¢c for PCBCK1, we created a kinase dead
mutant, PCBCK1vK575R, and tested growth at both temper-
atures. As shown in Fig. 4B, PCBCK1vK575R grows normally
at 30 ‡C but not at 37 ‡C. This single site mutation in the
kinase domain, changing the conserved lysine to an arginine,
has been shown to abolish kinase activity in analogous ki-
nases [39^41]. For further con¢rmation, we veri¢ed expression
of PCBCK1 at the elevated temperature by immunoblotting
protein lysates from these yeast grown at 25‡C and 37‡C (Fig.
5).
3.4. PCBCK1 is a functional kinase
PCBCK1 was immunoprecipitated and assayed for kinase
activity with and without PHAS-I as a substrate. PCBCK1 is
Fig. 4. PCBCK1 complements cell-wall integrity signaling to allow
fungal growth at elevated temperature. S. cerevisiae bck1v yeast
transformed with PCBCK1, SCBCK1, or LACZ grow normally at
30‡C (A). PCBCK1 expression supports growth at 37‡C as does the
wild-type SCBCK1 (as a positive control), however the mutant yeast
expressing LACZ (as a negative control) do not grow at the ele-
vated temperature. Addition of 1 M sorbitol to the plates amelio-
rates this e¡ect by osmotic stabilization of the cell wall. S. cerevisiae
bck1v yeast transformed with PCBCK1vK575R, the kinase dead mu-
tant, grow normally at 30 ‡C but do not grow at the elevated tem-
perature (B).
Fig. 5. Protein expression of PCBCK1 at elevated temperature. To
further verify that PCBCK1 functionally complements cell-wall in-
tegrity in yeast at elevated temperature, we immunoblotted protein
lysates from S. cerevisiae bck1v yeast expressing PCBCK1 which
were grown at 25‡C or 37‡C in galactose minimal media for 72 h.
An appropriately sized 92-kDa protein is observed under both
growth conditions.
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an active kinase as judged by its observed autophosphoryla-
tion (Fig. 6A), and its ability to phosphorylate PHAS-I (Fig.
6B). No di¡erence in phosphorylation of PHAS-I was ob-
served in yeast grown at 25‡C or temperature-shifted to
37‡C. This is likely due to autophosphorylation of PCBCK1
and is consistent with the similar observation that S. cerevisiae
STE11 (the yeast MEKK that functions in pheromone-
induced mating) does not have increased kinase activity
nor enhanced mRNA expression after exposure to mating
pheromone [41]. Testing of the kinase dead mutant,
PCBCK1vK575R, under identical conditions reveals no ob-
served autophosphorylation (Fig. 6A) or PHAS-I substrate
phosphorylation (Fig. 6B).
3.5. PCBCK1 restores cell-wall integrity signaling to maintain
expression of the temperature-inducible glucan synthetase,
FKS2, at elevated temperature
FKS2 mRNA expression during elevated temperature re-
quires an intact cell-wall integrity MAPK pathway if the
heat stress persists beyond 60^120 min, which functions to
prevent fungal lysis due to cell-wall instability [22]. To deter-
mine if PCBCK1 complements this signaling defect in bck1v
yeast to maintain expression of FKS2 at elevated temperature,
we analyzed FKS2 mRNA expression in S. cerevisiae bck1v
yeast expressing PCBCK1 grown at 25‡C or temperature-
shifted to 37‡C at various time points. PCBCK1 restored
the MAPK signaling defect to maintain FKS2 mRNA expres-
sion after 60 min of elevated temperature (Fig. 7A). This is in
contrast to S. cerevisiae bck1v yeast which demonstrate re-
duced FKS2 expression at 60 min and absence of FKS2 ex-
pression at 120 min at the elevated temperature (Fig. 7B).
These data support the function of PCBCK1 in the cell-wall
integrity MAPK pathway within S. cerevisiae.
4. Discussion
The opportunistic fungus P. carinii remains an important
cause of pneumonia in patients infected with HIV, and in
patients with altered cellular immunity [4,47,48]. Our labora-
tory has been investigating components of the P. carinii cell
wall, and we and others have found that the P. carinii cyst has
a cell wall enriched in L-glucans, chitins, and a family of
glycoproteins designated as gpA or MSG [6,23,49^53]. We
have previously identi¢ed and characterized a L-1-3-glucan
synthetase from P. carinii, GSC1, which is capable of incor-
porating 5P-diphosphoglucose into glucan [23]. In this inves-
tigation we describe the identi¢cation of a MEKK gene from
P. carinii, PCBCK1, which functions in the cell-wall integrity
MAPK cascade in S. cerevisiae. Yeast with the BCK1 gene
deleted are defective in cell-wall assembly and lyse at the non-
permissive temperature of 37‡C. Our results show that expres-
sion of PCBCK1 complements the bck1v defect in S. cerevi-
siae, restoring growth at the elevated temperature. Further,
restoration of cell-wall integrity MAPK signaling with
PCBCK1 speci¢cally allows maintenance of the yeast down-
Fig. 6. PCBCK1 exhibits functional kinase activity. PCBCK1 was
immunoprecipitated from S. cerevisiae bck1v yeast and tested in a
kinase reaction without a substrate to demonstrate autophosphory-
lation (A, lane A). The kinase dead mutant, PCBCK1vK575R, does
not have an observed autophosphorylation (A, lane B). Next,
PCBCK1 was immunoprecipitated from S. cerevisiae bck1v yeast
grown at 25‡C or temperature-shifted to 37‡C and tested in a kinase
reaction using PHAS-I as a phosphorylation substrate. As shown in
B, there was no di¡erence in observed phosphorylation at the two
temperatures. Likewise, the kinase dead mutant, PCBCK1vK575R,
cannot phosphorylate the substrate. The 37‡C time point shown is
at 2 h, and is no di¡erent from time points tested at 30 or 60 min.
Fig. 7. PCBCK1 complements cell-wall integrity signaling to allow
maintenance of FKS2 mRNA expression at elevated temperature.
FKS2 expression is not detected in S. cerevisiae bck1v yeast express-
ing PCBCK1 grown at 25‡C, however FKS1 expression is present.
When these yeast are shifted to 37‡C, we identify FKS2 expression
starting in 20 min, increasing at 60 min, and stabilizing at 120 min
(A). This is in contrast to the mutant yeast which have a disruption
in cell-wall integrity MAPK signaling due to deletion of their BCK1
gene (S. cerevisiae bck1v). These yeast demonstrate FKS2 induction
at 37‡C in 20 min, a reduction at 60 min, and loss of FKS2 expres-
sion at 120 min (B). ACT1 indicates S. cerevisiae actin.
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stream temperature-inducible L-1-3-glucan synthetase FKS2
with elevated temperature.
Activation of the cell-wall integrity MAPK pathway is a
survival mechanism for fungi which experience environmental
stress, such as elevated temperature. The fungal cell wall,
comprised primarily of glucan, is in constant £ux during nor-
mal cellular growth [54]. In S. cerevisiae, subunits of the L-1-
3-glucan synthetase enzymes are encoded by the genes FKS1
and FKS2 [28,29]. These enzymes are the principal means that
glucose gets incorporated in the fungal cell wall as L-1,3-glu-
can. Under normal growth conditions, FKS1 is the predom-
inantly expressed subunit and its level £uctuates slightly with
the cell cycle. When the yeast are exposed to thermal stress,
FKS2 is induced through dual mechanisms involving calci-
neurin and the cell-wall integrity MAPK pathway. Induction
of FKS2 mRNA occurs within 20 min of heat shock, and
continued expression of FKS2 mRNA requires a functional
cell-wall integrity MAPK pathway [22].
P. carinii exists in the alveolar spaces of the infected host.
Human-to-human transmission is the suspected route of ac-
quisition of this infection in immunocompromised individuals,
however this is controversial [15,16,55^57]. It is uncertain
whether P. carinii has a natural environment similar to
many other fungi. It is intriguing that P. carinii nucleic acids
have been identi¢ed in natural settings outside of the lung, but
a de¢nite ecological niche has not yet been identi¢ed [10^
12,58]. If P. carinii experiences temperature shifts, ranging
from 25‡C (room temperature) to 37‡C (body temperature),
we can envision that P. carinii utilizes a MAPK cell-wall in-
tegrity pathway to stabilize its cell wall similar to other fungi.
Interference of the cell-wall integrity MAPK pathway in
P. carinii is an attractive target for novel drug development
because the machinery for glucan biosynthesis is not present
within mammals. Since it is impossible to culture P. carinii,
and the methodology for gene disruption and isolation of
clonal populations of mutant P. carinii organisms is not cur-
rently possible, we had to analyze the function of the P. carinii
MEKK gene in a closely related yeast, S. cerevisiae. Our re-
sults suggest that P. carinii uses signaling molecules to main-
tain cell-wall integrity similar to those found in closely related
fungi. Within the infected lung, P. carinii would be exposed to
temperatures of 37‡C or higher during fever. The function of
PCBCK1 is likely necessary to maintain the integrity of the
P. carinii cell wall under these conditions, similar to the func-
tion of the S. cerevisiae BCK1 protein.
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